Early Lung Cancer Detection Program (ELUCiD) Revenue

Medical Practices • Sydney, New South Wales, Australia • 1-10 Employees

Early Lung Cancer Detection Program (ELUCiD) revenue & valuation

Annual revenue	$171,110
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Medical Practices industry and current estimated revenues	$547,552
Total funding	No funding

Key Contact at Early Lung Cancer Detection Program (ELUCiD)

Alvin Ing

Director

Company overview

Headquarters	Technology Pl, 203, Macquarie Park, New South Wales 2113, AU
Website	mqhealth.org.au
NAICS	62
Keywords	Radiation Oncology, Radiology, Thoracic Surgery, Medical Oncology, Interventional Pulmonology, Thoracic Medicine
Founded	2024
Employees	1-10

About Early Lung Cancer Detection Program (ELUCiD)

In July 2025, the federal government is introducing a National Lung Cancer Screening Program (NLCSP) targeting the population most at risk, aiming for early detection of lung cancer. ELUCiD has positioned itself at the forefront of the clinical response to this program with the implementation of a comprehensive lung cancer screening service incorporating its existing services together with an expanding array of: - CNC lead Rapid triage of referrals - Clinics - World-leading diagnostic procedures - GP support services - Multidisciplinary team discussions - Comprehensive treatment options

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Funding Data

Early Lung Cancer Detection Program (ELUCiD) has never raised funding before.

Frequently asked questions

Early Lung Cancer Detection Program (ELUCiD) is located in Sydney, New South Wales, AU.

Early Lung Cancer Detection Program (ELUCiD) generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.

Early Lung Cancer Detection Program (ELUCiD) has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Early Lung Cancer Detection Program (ELUCiD) was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.

Early Lung Cancer Detection Program (ELUCiD) has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Early Lung Cancer Detection Program (ELUCiD)

Alvin Ing

Director

4.8

40,000 users